2022 Q3 Form 10-Q Financial Statement

#000157570522000602 Filed on August 18, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.300M $445.0K $442.1K
YoY Change -95.63% -32.64% -87.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $247.9K $245.1K $242.6K
YoY Change 142.29% 7088.56% 5208.32%
% of Gross Profit
Operating Expenses $1.300M $445.0K $442.1K
YoY Change -95.64% -32.64% -87.67%
Operating Profit
YoY Change
Interest Expense -$4.940K $4.891K $4.835K
YoY Change -77.66% -95.07% -68.91%
% of Operating Profit
Other Income/Expense, Net $6.420K -$2.397K $1.759K
YoY Change 41.41% -102.59% -113.29%
Pretax Income -$7.286M -$442.6K -$440.3K
YoY Change -75.57% -41.24% -87.76%
Income Tax
% Of Pretax Income
Net Earnings -$7.286M -$442.6K -$440.3K
YoY Change -75.57% -41.24% -87.76%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 -$1.220K -$1.214K
COMMON SHARES
Basic Shares Outstanding 362.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.860K $3.270K $4.200K
YoY Change -23.32% 179.49% 2700.0%
Cash & Equivalents $2.857K $3.272K $4.196K
Short-Term Investments
Other Short-Term Assets $11.18K $18.25K $19.27K
YoY Change -40.53% 17.14% 22.58%
Inventory
Prepaid Expenses $11.18K $18.25K $19.27K
Receivables
Other Receivables
Total Short-Term Assets $14.04K $21.52K $23.47K
YoY Change -37.67% 28.5% 47.88%
LONG-TERM ASSETS
Property, Plant & Equipment $1.273K $1.569K $1.799K
YoY Change -43.42% 50.87% -55.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.342K $6.047M $6.292M
YoY Change -99.94% 581339.04% 156423.08%
TOTAL ASSETS
Total Short-Term Assets $14.04K $21.52K $23.47K
Total Long-Term Assets $4.342K $6.047M $6.292M
Total Assets $18.38K $6.068M $6.316M
YoY Change -99.73% 34011.8% 31653.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.381M $2.399M $2.359M
YoY Change 8.31% 183.9% 200.39%
Accrued Expenses $161.6K $171.5K $165.9K
YoY Change 4.66% 16.05% 13.09%
Deferred Revenue
YoY Change
Short-Term Debt $177.0K $251.8K $253.4K
YoY Change -26.07% 12.34% -5.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.062M $4.028M $3.970M
YoY Change 14.75% 93.59% 97.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.062M $4.028M $3.970M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.062M $4.028M $3.970M
YoY Change 14.75% 93.59% 97.5%
SHAREHOLDERS EQUITY
Retained Earnings -$67.07M -$59.78M -$59.34M
YoY Change 45.64%
Common Stock $3.748K $3.633K $3.633K
YoY Change 9.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.043M $2.041M $2.345M
YoY Change
Total Liabilities & Shareholders Equity $18.38K $6.068M $6.316M
YoY Change -99.73% 34011.8% 31653.12%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.286M -$442.6K -$440.3K
YoY Change -75.57% -41.24% -87.76%
Depreciation, Depletion And Amortization $247.9K $245.1K $242.6K
YoY Change 142.29% 7088.56% 5208.32%
Cash From Operating Activities $5.640K -$350.00 -$4.160K
YoY Change -105.54% -99.36% -91.82%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0% -100.0% -100.0%
NET CHANGE
Cash From Operating Activities 5.640K -350.0 -4.160K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 5.640K -350.0 -4.160K
YoY Change -105.37% -97.32% -79.58%
FREE CASH FLOW
Cash From Operating Activities $5.640K -$350.00 -$4.160K
Capital Expenditures $0.00 $0.00
Free Cash Flow $5.640K -$350.00
YoY Change -105.68% -99.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
usd
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
usd
dei Entity Address City Or Town
EntityAddressCityOrTown
Newport Beach,
dei Entity Central Index Key
EntityCentralIndexKey
0001497649
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022Q2 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
usd
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
gstx Issuance Of Short Term Note Payable
IssuanceOfShortTermNotePayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
gstx Debt Discount On Convertible Notes
DebtDiscountOnConvertibleNotes
usd
CY2021Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
usd
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-174194
dei Entity Registrant Name
EntityRegistrantName
GRAPHENE & SOLAR TECHNOLOGIES LTD
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2888719
dei Entity Address Address Line1
EntityAddressAddressLine1
23 Corporate Plaza Drive,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92660
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
478-8387
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
362823733 shares
CY2022Q2 us-gaap Cash
Cash
3272 usd
CY2021Q3 us-gaap Cash
Cash
3728 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18252 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18797 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
21524 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
22525 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81629 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81629 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1569 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2250 usd
CY2022Q2 gstx Intellectual Property At Cost Net Of Amortization
IntellectualPropertyAtCostNetOfAmortization
837417 usd
CY2021Q3 gstx Intellectual Property At Cost Net Of Amortization
IntellectualPropertyAtCostNetOfAmortization
837417 usd
CY2022Q2 gstx Intellectual Property At Cost
IntellectualPropertyAtCost
6042328 usd
CY2021Q3 gstx Intellectual Property At Cost
IntellectualPropertyAtCost
6777424 usd
CY2022Q2 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2021Q3 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2094 usd
CY2022Q2 us-gaap Assets
Assets
6068490 usd
CY2021Q3 us-gaap Assets
Assets
6803174 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2398987 usd
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2197894 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
171476 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
154412 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1205635 usd
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
947826 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
77223 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
52703 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
100747 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
168967 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
173038 usd
CY2022Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
5567 usd
CY2021Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
6383 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4027855 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3539553 usd
CY2022Q2 us-gaap Liabilities
Liabilities
4027855 usd
CY2021Q3 us-gaap Liabilities
Liabilities
3539553 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
362823733 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
343237369 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
3633 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3437 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62427147 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49922922 usd
CY2022Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
795000 usd
CY2021Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
720000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59784324 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46050640 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-189179 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-107902 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2040635 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6068490 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6803174 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
166256 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
625077 usd
us-gaap Professional Fees
ProfessionalFees
12892711 usd
us-gaap Professional Fees
ProfessionalFees
4755431 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
278762 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35567 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
829218 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
116917 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
445018 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
660664 usd
us-gaap Operating Expenses
OperatingExpenses
13721929 usd
us-gaap Operating Expenses
OperatingExpenses
4872348 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
445018 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
660664 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13721929 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4872348 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7288 usd
CY2021Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6656 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
18564 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11165 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
4891 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
99267 usd
us-gaap Interest Expense
InterestExpense
30319 usd
us-gaap Interest Expense
InterestExpense
129094 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2397 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92611 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11755 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
117929 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-442621 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-753255 usd
us-gaap Net Income Loss
NetIncomeLoss
-13733684 usd
us-gaap Net Income Loss
NetIncomeLoss
-4990277 usd
CY2022Q2 gstx Net Comprehensive Loss
NetComprehensiveLoss
-304644 usd
CY2021Q2 gstx Net Comprehensive Loss
NetComprehensiveLoss
-737177 usd
gstx Net Comprehensive Loss
NetComprehensiveLoss
-13652409 usd
gstx Net Comprehensive Loss
NetComprehensiveLoss
-4939030 usd
CY2022Q2 gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2021Q2 gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.04
gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.02
CY2022Q2 gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
362823733 shares
CY2021Q2 gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
255844773 shares
gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
360954236 shares
gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
252945462 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46921 usd
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
12382500 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9246 usd
us-gaap Profit Loss
ProfitLoss
-12850758 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2833038 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-47456 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-440305 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2345277 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
137979 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-442621 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2040635 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1672275 usd
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1450000 shares
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
84738 usd
CY2020Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
405000 usd
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-82637 usd
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-639185 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1904359 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30476 usd
CY2021Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
43475 usd
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
3422500 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15312 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-3597837 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1990433 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22879 usd
CY2021Q2 gstx Shares Issued In Connection With Conversion Of Notes Payable
SharesIssuedInConnectionWithConversionOfNotesPayable
127050 usd
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
481000 usd
CY2021Q2 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
33885 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16078 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-753225 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2062796 usd
us-gaap Profit Loss
ProfitLoss
-13733684 usd
us-gaap Profit Loss
ProfitLoss
-4990277 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12382500 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4308500 usd
us-gaap Depreciation
Depreciation
611 usd
us-gaap Depreciation
Depreciation
12403 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
735096 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13943 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
106670 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
225056 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
191526 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17064 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
21714 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2094 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-15579 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
312045 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
146633 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49463 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-218410 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
381 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-381 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46921 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
138093 usd
gstx Issuance Of Short Term Note Payable
IssuanceOfShortTermNotePayable
133785 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46921 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
271878 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2086 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-51929 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-456 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1158 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3728 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3272 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1170 usd
gstx Debt Discount On Convertible Notes
DebtDiscountOnConvertibleNotes
77360 usd
gstx Conversion Of Loan Principal Accrued Interest Shares
ConversionOfLoanPrincipalAccruedInterestShares
127050 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
gstx Net Income Losses
NetIncomeLosses
59784322 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zcN6BqjcKNEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_865_zX7BpDI7VsP9">Use of Estimates</span> -</i> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q2 us-gaap Cash
Cash
3272 usd
CY2021Q2 us-gaap Cash
Cash
1170 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
77912 usd
CY2021Q3 us-gaap Notes Payable
NotesPayable
60000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-837417 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6042328 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
12382500 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
405000 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
9485000 usd
CY2022Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
13500000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z0rwPJiYIb4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86D_zxuO4is4ug3e">Reclassifications</span></i> - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
168967 usd
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
168967 usd
CY2022Q2 us-gaap Other Loans Payable
OtherLoansPayable
5567 usd
CY2021Q3 us-gaap Other Loans Payable
OtherLoansPayable
5623 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
99701 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96710 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
39701 usd
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
36710 usd
CY2022Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
70747 usd
CY2021Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
70747 usd
CY2022Q2 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
1205635 usd
CY2021Q3 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
947826 usd
us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
1200000 shares
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
46921 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
5778366 shares
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
6879745 usd

Files In Submission

Name View Source Status
0001575705-22-000602-index-headers.html Edgar Link pending
0001575705-22-000602-index.html Edgar Link pending
0001575705-22-000602.txt Edgar Link pending
0001575705-22-000602-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gstx-20220630.xsd Edgar Link pending
gstx_2q22.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
gstx-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gstx-20220630_def.xml Edgar Link unprocessable
gstx-20220630_pre.xml Edgar Link unprocessable
gstx_2q22_htm.xml Edgar Link completed
gstx-20220630_cal.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending